Laura L. (Melendres) Koth MD
Pleural Disease
Assistant Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2961
Fax+1 415-353-2568
Dr. Koth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1997
Harvard Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 1998 - 2027
MA State Medical License 1996 - 1999
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Genomic Research in Sarcoidosis Start of enrollment: 2013 May 01
- Genomic Research in Alpha-1 Antitrypsin Deficiency Start of enrollment: 2013 May 01
- Use of CXCL9 as a Biomarker of Acthar Efficacy Start of enrollment: 2022 Nov 03
Publications & Presentations
PubMed
- 3 citationsTrends in All-Cause Mortality Among US Veterans With Sarcoidosis, 2004-2022.Mohamed I Seedahmed, Mohamed T Albirair, Aaron D Baugh, Walid F Gellad, S Mehdi Nouraie
Chest. 2025-05-01 - Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic Impairment.Bryan S Benn, William L Lippitt, Isabel Cortopassi, G K Balasubramani, Eduardo J Mortani Barbosa Jr
Chest. 2024-11-01 - 6 citationsDiscovery of Two Novel Immunoepitopes and Development of a Peptide-based Sarcoidosis Immunoassay.Changya Peng, Jaya Talreja, Brennen Steinbauer, Kazuhiko Shinki, Laura L Koth
American Journal of Respiratory and Critical Care Medicine. 2024-10-01
Grant Support
- Development of Clinical Prediction Models for Pulmonary Outcomes in SarcoidosisUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2026
- Development of Clinical Prediction Models for Pulmonary Outcomes in SarcoidosisUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2026
- Development of Clinical Prediction Models for Pulmonary Outcomes in SarcoidosisUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2026
- Genomic Phenotyping And Mechanisms In Sarcoidosis And AATNational Heart, Lung, And Blood Institute2012
- Immunophenotyping And Lymphocyte Effector Functions In SarcoidosisNational Institute Of Allergy And Infectious Diseases2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
